Register to receive a free U.S. Market Report Suite for Diagnostic Ophthalmic Devices – MedSuite report synopsis and brochure
Johnson & Johnson Vision announced the launch of its next generation of personalized LASIK treatment, the iDESIGN Refractive Studio. The iDESIGN Refractive Studio received U.S. Food and Drug Administration (FDA) approval in June making it the only system to use topography-integrated, wavefront-guided technology. This allows doctors to take a precise measurement of the eye inside and out to deliver a LASIK procedure personalized to the individual patient. It is approved for myopia, hyperopia, and mixed astigmatism. Additionally, it is the only available LASIK technology platform indicated for Wavefront-guided Monovision LASIK in presbyopic myopic patients. Monovision is a procedure designed for patients over 40 years old who are experiencing blurry near vision due to aging of their eyes. 96% of patients reported a decrease in wearing glasses six months after Monovision LASIK with the Customvue System.
“Johnson & Johnson Vision’s new iDESIGN Refractive Studio allows surgeons to measure the entire visual pathway and the cornea curvature to create an optical fingerprint unique to each patient’s eye,” said Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision. “This represents an important milestone in LASIK where the procedure is now truly tailored to the individual. When we measure better, we can treat better.”
Five measurements are taken in a single one-click capture sequence with the iDESIGN Refractive Studio, offering a new level of personalization for patients. Each treatment plan begins with a wavefront analysis to measure how light travels inside the eye, detailing the imperfections in a patient’s vision. The corneal topography scans the outside surface of the eye, measuring and analyzing tiny variations in curvature and elevation. The combination of the two measurements delivers a one-of-a-kind LASIK procedure tailored for each eye.
“The availability of the iDESIGN Refractive Studio in the U.S. is significant for both the ophthalmic and patient community,” said Marc Odrich, MD, Medical Director, Refractive, Johnson & Johnson Vision and Associate Professor, University of Virginia. “We’re using LASIK technology that analyzes the entire eye inside and out. This allows us to take a customized approach specific to each patient’s corneal topographic data addressing the unique imperfections of that patient’s eyes. It is a further personalization of our unique technologies.”
iDESIGN Refractive Studio is now commercially available and surgeons can contact their local sales representative for more information.
For Further Information
More on the interventional ophthalmic market in the U.S can be found in a series of reports published by iData Research entitled the U.S. Market Report Suite for Diagnostic Ophthalmic Devices. The suite covers reports on the following markets: ophthalmic coherence tomography, fundus cameras, data management systems, slit lamps, perimeters, tonometers, autorefractors/keratometers, binocular indirect ophthalmoscopes, ophthalmic ultrasound devices, wavefront abberometers, corneal topographers, and optical biometers.
The iData report series on ophthalmic devices covers the U.S. and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about ophthalmic device market data, register online or email us at firstname.lastname@example.org for a U.S. Market Report Suite for Diagnostic Ophthalmic Devices brochure and synopsis.